Biodexa Pharmaceuticals share price logo

Biodexa Pharmaceuticals

NASDAQ: BDRX

$0.87

-0.03

(-3.54%)

as on

Biodexa Pharmaceuticals Stock Performance

as on August 31, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.83
    $0.88
    downward going graph

    4.60%

    Downside

    1.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.83
    $59.40
    downward going graph

    4.56%

    Downside

    6727.59%

    Upside

    downward going graph

Biodexa Pharmaceuticals share price movements today

Previous Close
$0.90
Open
$0.87
Volume
182.9K
Market Cap
$893.3K
Day's Low - High
$0.83 - $0.88
52 Week Low - High
$0.83 - $59.40

Biodexa Pharmaceuticals Historical Returns

1 Month Return
-34.23 %
3 Month Return
-74.98 %
1 Year Return
-96.87 %
3 Year Return
-99.99 %
5 Year Return
0 %

Biodexa Pharmaceuticals Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$893.3K

EPS (TTM)

-536.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-2.4854761904761906

PEG Ratio

-0.00001267318525798526

EBITDA

-8.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-55.81%

Biodexa Pharmaceuticals Stock Valuation

Track how Biodexa Pharmaceuticals P/E has moved over time to understand its valuation trends.

Biodexa Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-0.88x)

December 31, 2021

Industry (-2.49x)

December 31, 2025

Today (-0.02x)

December 31, 2025

Highest (-0.02x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.02x

Biodexa Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Biodexa Pharmaceuticals image
Biodexa Pharmaceuticals
BUY$893.3KNANA0.00%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$137.2B170.45%31.9286.04%NA
Moderna image
Moderna
BUY$55.1B-63.37%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$85.8B17.94%19.984.86%0.44%

Stock Returns calculator for Biodexa Pharmaceuticals Stock including INR - Dollar returns

The Biodexa Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Biodexa Pharmaceuticals investment value today

Current value as on today

₹3,404

Returns

-₹96,596

(-96.6%)

Returns from Biodexa Pharmaceuticals Stock

-₹96,859 (-96.86%)

Dollar Impact

₹263 (+0.26%)

Analyst Recommendation on Biodexa Pharmaceuticals Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceuticals. Average target price of $10.22

Biodexa Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceuticals.

What analysts predicted

91.49%UPSIDE

Target Price

$10.22

Current Price

$0.87

Analyzed by

7 Analysts

Target

$10.22

Biodexa Pharmaceuticals target price $10.22, a slight upside of 91.49% compared to current price of $0.87. According to 7 analysts rating.

Indian Investors' Interest in Biodexa Pharmaceuticals Stock

Search interest for Biodexa Pharmaceuticals Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Biodexa Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
-
-
-
-
Gross Profit
-1
-2
-1
-2
-1
-2
-2
-3
-1
0
Operating Income
-3
-3
-3
-3
-4
-3
-4
-4
-4
-4
EBITDA
-3
-3
-3
-3
-4
-2
-3
-4
-3
-4
Interest Expense
-
-
-
-
-
-
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-2
-3
-5
-3
-3
-3
-2
-3
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
-2
-3
-4
-3
-3
-3
-2
-3
-2
Net Profit Margin
-401.25%
-1393.79%
-415.60%
-1067.97%
-655.37%
-2612.05%
0.00%
0.00%
0.00%
0.00%

Biodexa Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
0
0
0
0
0
-
-
Gross Profit
-7
-7
-7
-5
-4
-4
-3
-5
0
Operating Income
-11
-11
-11
-23
-6
-8
-8
-9
-8
EBITDA
-10
-10
-9
-22
-5
-8
-7
-9
-8
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
0
0
0
0
0
Income Before Tax
-12
-12
-10
-23
-6
-8
-7
-5
-6
Income Tax Expense
-1
-2
-1
-1
0
0
0
0
0
Net Income
-11
-10
-10
-22
-5
-7
-7
-5
-6
Net Profit Margin
-742.16%
-382.92%
-1063.65%
-1669.10%
-705.19%
-631.19%
-967.45%
0.00%
0.00%

Biodexa Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
-3
-2
-3
-4
-3
-3
-3
-2
-3
-2
Operating Cash Flow
-3
-2
-3
-3
-3
-2
-4
-7
-3
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
8
0
0
6
3
4
4
5
7
Change in Cash
-1
2
6
-1
1
0
5
-3
4
4

Biodexa Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-15
-10
-22
-5
-7
-7
-5
-6
Operating Cash Flow
-12
-13
-6
-9
-6
-7
-6
-12
-5
Investing Cash Flow
-1
9
-3
2
0
0
0
0
0
Financing Cash Flow
10
-6
18
3
8
0
10
8
12
Change in Cash
-4
-10
8
-3
2
-7
3
-4
6

Global Institutional Holdings in Biodexa Pharmaceuticals

Funds
Holdings
GAMMA Investing LLC
0%
UBS Group AG
0%
Rhumbline Advisers
0%
HRT FINANCIAL LLC
0%
Allied Private Wealth LLC
0.05%
See all

Insights on Biodexa Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.80M → -2.56M (in $), with an average increase of 48.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 22.0% return, outperforming this stock by 122.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 569.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BDRX stock has moved down by -27.7%

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTX240, for the treatment of gastrointestinal stromal tumors. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, nanotechnology used to dissolve insoluble drugs so that they can be administered in liquid form directly and locally into tumours; and MidaCore, a gold nanoparticle used for targeting sites of disease. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
OrganisationBiodexa Pharmaceuticals
Headquarters1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
IndustryBiotechnology
CEOMr. Stephen Anthony Stamp
E-voting on sharesClick here to vote

Key Management of Biodexa Pharmaceuticals

Name

Title

Dr. Gary A. Shangold CPI, FACOG, M.D.

Chief Medical Officer

Mr. Jim Kostka

Vice President & Head of US Clinical Operations

Ms. Noreen Bhatti

Vice President of Clinical Operations

Mr. Stephen Anthony Stamp

CEO & Director

Ms. Fiona Mary Sharp

Company Secretary, CFO & Director

Dr. Daniel Palmer MBA, Ph.D.

Vice President of Technology

Mr. Steve Ellul

Chief Business Officer

FAQs

What is Biodexa Pharmaceuticals share price today?

Biodexa Pharmaceuticals share price today is $0.87 as on at the close of the market. Biodexa Pharmaceuticals share today touched a day high of $0.88 and a low of $0.83.

What is the 52 week high and 52 week low for Biodexa Pharmaceuticals share?

Biodexa Pharmaceuticals share touched a 52 week high of $59.40 on and a 52 week low of $0.83 on . Biodexa Pharmaceuticals stock price today i.e. is closed at $0.87,which is 98.54% down from its 52 week high and 4.78% up from its 52 week low.

What is Biodexa Pharmaceuticals's market capitalisation today?

Biodexa Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Biodexa Pharmaceuticals Stock (BDRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biodexa Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceuticals Shares that will get you 1.7241 shares as per Biodexa Pharmaceuticals share price of $0.87 per share as on August 31, 2026 at 8:45 am IST.

What is the minimum amount required to buy Biodexa Pharmaceuticals Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceuticals (BDRX) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Biodexa Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Biodexa Pharmaceuticals share’s latest price of $0.87 as on August 31, 2026 at 8:45 am IST, you will get 11.4943 shares of Biodexa Pharmaceuticals. Learn more about fractional shares .